Healthy volunteers needed to test how common medications change a new drug's behavior
NCT ID NCT07449390
First seen Mar 18, 2026 · Last updated Apr 30, 2026 · Updated 8 times
Summary
This study looks at how two common drugs—carbamazepine (a CYP3A4 inducer) and itraconazole (a CYP3A4 inhibitor)—affect the levels of a single dose of AP31969 in the blood. 28 healthy adults aged 18-55 will take AP31969 alone and with each of the other drugs. The results will help understand how to adjust AP31969 dosing if it is used with these or similar medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON Early Phase Services, LLC
RECRUITINGSan Antonio, Texas, 78232, United States
Conditions
Explore the condition pages connected to this study.